helping orthopedic doctors help their patients during covid lockdown
Brand: Bioventus's DUROLANE hyaluronic acid (HA) injections for osteoarthritis (OA) knee pain.
Challenge: As clinics reduced hours and staggered appointments during the early days of COVID-19, the sales and marketing teams at Bioventus brainstormed new conversations to have with doctors to make things easier on their practice while still providing knee pain relief to patients.
Solution: We supported sales with a marketing piece that touted the timely benefits of using DUROLANE: longer-lasting relief than other HA injections, fewer office visits, a less crowded waiting room, and of course the ability to delay elective knee replacement surgeries.
Challenge: As clinics reduced hours and staggered appointments during the early days of COVID-19, the sales and marketing teams at Bioventus brainstormed new conversations to have with doctors to make things easier on their practice while still providing knee pain relief to patients.
Solution: We supported sales with a marketing piece that touted the timely benefits of using DUROLANE: longer-lasting relief than other HA injections, fewer office visits, a less crowded waiting room, and of course the ability to delay elective knee replacement surgeries.
reaching active patients starting to feel OA knee pain
Brand: Bioventus' DUROLANE hyaluronic acid (HA) injections for osteoarthritis (OA) knee pain.
Background and Challenge: OA is commonly perceived as an older person's malady, one of those ailments that comes with arriving at your 50s and 60s. But it also touches people in their 40s. We wanted to target this age group, as it aligns with the indications of DUROLANE for mild-to-moderate OA knee pain.
Solution: Partner with Spartan Races to promote DUROLANE to their audience of 30s and 40s fit men and women who participate in group physical challenges. We created banners for display at the races, and a content campaign of a series of "KneeMails" to educate about OA and introduce the benefits of DUROLANE.
Result: Continuous, large number of sign-ups for the email program.
Background and Challenge: OA is commonly perceived as an older person's malady, one of those ailments that comes with arriving at your 50s and 60s. But it also touches people in their 40s. We wanted to target this age group, as it aligns with the indications of DUROLANE for mild-to-moderate OA knee pain.
Solution: Partner with Spartan Races to promote DUROLANE to their audience of 30s and 40s fit men and women who participate in group physical challenges. We created banners for display at the races, and a content campaign of a series of "KneeMails" to educate about OA and introduce the benefits of DUROLANE.
Result: Continuous, large number of sign-ups for the email program.
a new amniotic formulation: MOTYS injections to relieve OA knee pain
Brand: Preparing marketing materials for eventual launch: Bioventus' MOTYS amniotic allograft injections for OA knee pain. "MOTYS" is from the Latin word meaning motion.
Background and Challenge: Introducing an amniotic tissue-based injection, a biologic product, to hasten the body's ability to heal itself and relieve pain. Raise awareness among physicians of MOTYS as an attractive alternative to platelet rich plasma -- offering greater potency and consistency across injections.
Solutions: Various shown below.
Background and Challenge: Introducing an amniotic tissue-based injection, a biologic product, to hasten the body's ability to heal itself and relieve pain. Raise awareness among physicians of MOTYS as an attractive alternative to platelet rich plasma -- offering greater potency and consistency across injections.
Solutions: Various shown below.
